08.25.2018 Issue 136

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Director Global Outcomes Research

Are you looking for a patient-focused company that will inspire you and support your career? If so, be empowered to take charge of your future at Takeda. Join us as an Director Global Outcomes Research in our Cambridge office.

Associate Director Health Economics

Associate Director Real World Evidence (RWE) and Epidemiology

Associate Director/ Director, Medical Affairs- HEOR

Watson Health - Outcomes Research Leader (HEOR)

Senior Research Analyst - HEOR

Senior Director, HEOR Oncology and Specialty - 1850018301

Adjunct Faculty, Economics of Health Care, on-line

Watson Health - Lead Research Analyst (Outcomes Research)

Watson Health - Senior SAS Programmer Analyst (Medical and healthcare claims data)

Dartmouth Probe: Welch Plagiarized Work from Colleague, Another Researcher

Pharma Fights Back Against States’ Laws Aimed at Lowering Prices

PBMs' Fees on Drugmakers Could Play Role in Drug Prices

Express Scripts Formulary Has Hep C, MS Exclusions

Group Says Medicare Part D Can Pull Back Rising Costs by Shifting Liability

Article: Rise of Digital Health Data Bolsters Interest in RWD

ISPOR Summit 2018 Set for Oct. 19

FDA OKs First-Ever RNA Interference Therapy

Industry Spotlight

Conferences Webinars
6th Annual Real-World Analytics Summit 2018
    September 1-2, Boston, Massachusetts

ESMO Academy 2018
    September 1-3, Oxford, U.K.

Identifying Evidence for NICE Economic Submissions
    September 5, York, U.K.

22nd Annual Merck Technology Symposium
    September 5-6, Long Branch, New Jersey

ISPOR Asia Pacific 2018
    September 8-11, Tokyo, Japan

The Next Generation PSP: How to Maximize Patient Outcomes and Boost Patient Experience Through More Advance PSP Design
    August 30

PROving Its Worth: How to Develop a PRO Strategy to Distinguish Your Product with Regulators and Payers
    September 12

Using Real World Evidence in the Real World Oncology Practice Setting
    September 18

Beyond Controlling for Confounding: Design Strategies to Avoid Selection Bias and Improve Efficiency in Observational Studies
    September 27

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment

ICER’s Reference Case for Economic Evaluations: Principles and Rationale

A Guide to Getting Started in HEOR/Market Access Medical Writing

Impact of Displaying in-EHR Patient Drug Prices With or Without Patient Savings Messages

Special Thanks to Our Partners:
            Evidera   HealthCore     University of FL
      Xcenda  OM1    Parexel   Jefferson   Dymaxium
      Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON    Truven